Skip to content

Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant

A Clinical Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant in Comparison With the Best Non-operative Treatment of Lumbar Spine Stenosis

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01057641
Enrollment
22
Registered
2010-01-27
Start date
2011-03-31
Completion date
2018-06-30
Last updated
2016-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spinal Stenosis

Keywords

PIDLSS, Spacer

Brief summary

Neurogenic intermittent claudication is a specific symptom complex occurring in patients with lumbar spinal stenosis. Characteristic of this disease is the occurrence of increasing leg, buttock or groin pain with or without lower back pain when walking a certain distance or reclining. Bending forward or sitting leads to a rapid pain relief. Lumbar spinal stenosis is defined as a reduction of the diameter of the spinal canal. The mechanism leading to stenosis is a remodeling and overgrowth of the spinal canal with osteophyte formation. Any loss of tissue or decrease of the disc height results in a relative laxity of the ligament structures and accelerates the degeneration of the spinal joints. As a therapy option, conservative therapy with oral analgesics and physical therapy is considered. This treatment can be intensified by adding epidural pain treatment. Is the conservative treatment not successful surgical intervention is necessary. In patients over 65 years of age operative decompression of the lumbar spinal stenosis constitutes the most common surgical operation of the spine. A relatively new therapy alternative is the interspinous process decompression (IPD). Studies have shown that the IPDs prevent narrowing of the spinal canal and neural foramens. The study is intended as a randomised, monocentre study to investigate the safety and the benefit of a minimally invasive percutaneous IPD-device in comparison with the best non-surgical operative treatment of lumbar spinal stenosis.

Interventions

PROCEDURESpacer

Implantation of a percutaneously implanted interspinous device (spacer)

OTHERphysiotherapy

physiotherapy

Sponsors

University of Cologne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female over 50 years of age 2. One, two, or three segment degenerative lumbar spinal stenosis (DLSS) 3. Symptoms of radiographically confirmed DLSS like leg, buttock, or groin pain with or without back pain and absence of a peripheral motoric deficit 4. Pain relief in inclination or sitting 5. Ability to walk over a distance of 50 m 6. Unsuccessful conservative therapy for 3 months under outpatient conditions 7. Informed consent

Exclusion criteria

1. Fixed motoric deficit 2. Cauda equina syndrome 3. Previous surgery of the lumbar spine 4. Severe osteoporosis of the vertebrae and/or of the hip 5. Spondylolisthesis more severe than Meyerding I (on scale of I-IV) 6. Metastasis of the vertebrae 7. Mentally disabled persons

Design outcomes

Primary

MeasureTime frame
Changes in subscores for bodily pain and physical function on SF-36baseline, 6 months

Secondary

MeasureTime frame
Measurement of walking distancebaseline, 6 months
Symptoms severity by applying the Zurich Claudication Questionaire (ZCQ)baseline, 6 months
Physical function by applying ZCQbaseline, 6 months
Post-treatment patient satisfaction by applying ZCQbaseline, 6 months
General health status (Quality of life) by applying SF-36baseline, 6 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026